From: Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions
Therapeutic target
Pharmacolological treatment
Gut-liver axis
Probiotics[34]
Dyslipidemia/Insulin Resistance
Omega-3 DHA (docosahexaenoic acid)[12]
TNF-α pathway
Pentoxifylline and anti-TNF-α[35]
FXRs pathway
Agonist of the farnesoid X receptor (FXR)[36]